Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
Lisa Imundo, MD
New York Presbyterian Hospital - Columbia Campus
New York, NY, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Marinka Twilt, MD, PhD, MSc
Alberta Children's Hospital
Calgary, AB, Canada
Disclosure(s): No financial relationships with ineligible companies to disclose
The ACR has developed new a guideline and recommendations around the management and care of patients with vasculitis, including Kawasaki disease. This session will discuss the recommendations and rationale for the Kawasaki disease guideline put forth by the ACR. The speaker will also discuss practical applications of the guideline in the context of clinical and patient-related care as it pertains to day-to-day practice.
Speaker: Sangeeta Sule, MD, PhD – Children's National Hospital
Speaker: Karen James, MD, MSc – University of Utah